Improved Long-Term Survival Rate in the Responders to Bortezomib, Cyclophosphamide, Dexamethasone Induction Therapy in a Transplant-Eligible Cohort of Predominantly Middle-Age Multiple Myeloma Patients
ANNALS OF SAUDI MEDICINE(2024)
关键词
Diagnosis Criteria
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要